TABLE 1

Unbound parameter estimates of the final population pharmacokinetic model for oxycodone and the stability of the parameters using bootstrap resampling validation



Original Data Set

Bootstrap Resampling

Estimate
RSE (%)
Mean
RSE (%)
CL (ml/min) 37.4 3.4 37.6 3.1
Vc (ml) 1010 5 1016 4.8
Q (ml/min) 4.37 19 4.40 19
Vper (ml) 230 13 234 13
QAV (ml/min) 45.1 7.9 45.2 8.1
fu (%) 74.3 7.1 74.3 6.7
RECblood (%)a 65.8 2.3 65.8 2.4
RECbrain (%)a 16.4 6 16.5 6.1
CLin (ml/min) 1.91 20 1.95 20
K p,uu 3.03 3.8 3.04 3.7
Interanimal Variability
    ωCL 0.14 33 0.14 34
    ωVc 0.16 36 0.16 39
    ωfu 0.28 51 0.26 52
    ωRECblood 0.10 28 0.097 30
    ωRECbrain 0.22 31 0.21 32
Residual Variability
    σprop,plasmab (%) 0.195 9.3 0.189 9.6
    σprop,bloodb (%) 0.171 8.1 0.169 8.5
    σprop,brainb (%) 0.152 18 0.143 20
    σadd,brainb (mg/ml) 0.226 42 0.224 43
    σadd,RECbloodc (mg/ml) 2.44 12 2.43 11
    σadd,RECbrainc (mg/ml)
2.07
12
2.03
12
  • a RECblood (%) and RECbrain (%) are the recoveries of the blood and brain microdialysis probes, respectively.

  • b Oxycodone.

  • c Oxycodone-D3.